Cyclic AMP response element-binding protein is required in excitatory neurons in the forebrain to sustain wakefulness.
CREM
locus coeruleus
sleep
sleep deprivation
slow wave activity
Journal
Sleep
ISSN: 1550-9109
Titre abrégé: Sleep
Pays: United States
ID NLM: 7809084
Informations de publication
Date de publication:
11 06 2021
11 06 2021
Historique:
received:
06
08
2020
revised:
15
10
2020
pubmed:
6
12
2020
medline:
1
7
2021
entrez:
5
12
2020
Statut:
ppublish
Résumé
The molecular and intracellular signaling processes that control sleep and wake states remain largely unknown. A consistent observation is that the cyclic adenosine monophosphate (AMP) response element-binding protein (CREB), an activity-dependent transcription factor, is differentially activated during sleep and wakefulness. CREB is phosphorylated by the cyclic AMP/protein kinase A (cAMP/PKA) signaling pathway as well as other kinases, and phosphorylated CREB promotes the transcription of target genes. Genetic studies in flies and mice suggest that CREB signaling influences sleep/wake states by promoting and stabilizing wakefulness. However, it remains unclear where in the brain CREB is required to drive wakefulness. In rats, CREB phosphorylation increases in the cerebral cortex during wakefulness and decreases during sleep, but it is not known if this change is functionally relevant to the maintenance of wakefulness. Here, we used the Cre/lox system to conditionally delete CREB in the forebrain (FB) and in the locus coeruleus (LC), two regions known to be important for the production of arousal and wakefulness. We used polysomnography to measure sleep/wake levels and sleep architecture in conditional CREB mutant mice and control littermates. We found that FB-specific deletion of CREB decreased wakefulness and increased non-rapid eye movement sleep. Mice lacking CREB in the FB were unable to sustain normal periods of wakefulness. On the other hand, deletion of CREB from LC neurons did not change sleep/wake levels or sleep/wake architecture. Taken together, these results suggest that CREB is required in neurons within the FB but not in the LC to promote and stabilize wakefulness.
Identifiants
pubmed: 33277644
pii: 6024523
doi: 10.1093/sleep/zsaa267
pmc: PMC8193557
pii:
doi:
Substances chimiques
Cyclic AMP Response Element-Binding Protein
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIA NIH HHS
ID : P01 AG017628
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007953
Pays : United States
Informations de copyright
© Sleep Research Society 2020. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com.
Références
Science. 1996 Nov 15;274(5290):1211-5
pubmed: 8895474
Hum Mol Genet. 2016 Mar 1;25(5):837-52
pubmed: 26604145
Mol Brain. 2012 May 14;5:14
pubmed: 22583753
Neurol Clin. 2019 Aug;37(3):475-486
pubmed: 31256784
PLoS One. 2013 Nov 14;8(11):e81554
pubmed: 24244744
Trends Neurosci. 2005 Aug;28(8):436-45
pubmed: 15982754
J Neurosci. 1996 Nov 1;16(21):7010-20
pubmed: 8824337
Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15939-44
pubmed: 20696898
Genesis. 2006 Oct;44(10):454-64
pubmed: 16981198
J Neurosci. 1981 Aug;1(8):876-86
pubmed: 7346592
Hum Neurobiol. 1982;1(3):195-204
pubmed: 7185792
Curr Opin Neurobiol. 2001 Apr;11(2):180-7
pubmed: 11301237
Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4481-6
pubmed: 9539763
EMBO J. 1996 Mar 1;15(5):1098-106
pubmed: 8605879
J Neurosci. 2010 Oct 27;30(43):14543-51
pubmed: 20980612
Electroencephalogr Clin Neurophysiol. 1981 May;51(5):483-95
pubmed: 6165548
Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5647-51
pubmed: 8202542
Learn Mem. 2003 May-Jun;10(3):168-76
pubmed: 12773581
J Neurosci. 1991 Oct;11(10):3135-45
pubmed: 1682425
Curr Opin Neurobiol. 2017 Jun;44:186-192
pubmed: 28577468
Nat Neurosci. 2001 Nov;4(11):1108-15
pubmed: 11687816
Nat Genet. 2002 May;31(1):47-54
pubmed: 11967539
Annu Rev Neurosci. 1998;21:127-48
pubmed: 9530494
FASEB J. 2008 Aug;22(8):2872-9
pubmed: 18424767
Nature. 2009 Oct 22;461(7267):1122-5
pubmed: 19847264
J Neurochem. 2010 Nov;115(3):563-73
pubmed: 20367754
Physiol Rev. 2009 Jan;89(1):121-45
pubmed: 19126756
Trends Neurosci. 2010 May;33(5):230-40
pubmed: 20223527
Brain Res. 1974 Jul 5;74(1):19-40
pubmed: 4152613
J Neurosci. 1996 Nov 1;16(21):6999-7009
pubmed: 8824336
Neuron. 2010 Dec 22;68(6):1023-42
pubmed: 21172606
Neuropsychopharmacology. 2002 Nov;27(5):869-73
pubmed: 12431861
J Psychiatry Neurosci. 2010 Jul;35(4):221-8
pubmed: 20569648
J Neurosci. 2000 May 15;20(10):3830-42
pubmed: 10804223
Neurobiol Aging. 2012 Jan;33(1):195.e13-26
pubmed: 20619936
J Neurosci. 2007 Jun 6;27(23):6128-40
pubmed: 17553985
J Neurosci. 2000 Nov 1;20(21):8138-43
pubmed: 11050136
J Neurosci. 2000 Dec 15;20(24):9187-94
pubmed: 11124996
Genesis. 2000 Feb;26(2):133-5
pubmed: 10686608
Nature. 2007 Nov 15;450(7168):420-4
pubmed: 17943086
J Neurosci. 2001 Apr 15;21(8):2610-21
pubmed: 11306614
Cell. 1999 Aug 20;98(4):437-51
pubmed: 10481909
Neuron. 2002 Aug 15;35(4):605-23
pubmed: 12194863
Metabolism. 1996 Aug;45(8 Suppl 1):4-7
pubmed: 8769368
Neuron. 2001 May;30(2):345-54
pubmed: 11394998
Prog Brain Res. 2006;153:243-52
pubmed: 16876579
Ann N Y Acad Sci. 2008;1129:335-49
pubmed: 18591493
J Neurophysiol. 2003 Aug;90(2):1152-9
pubmed: 12711709
J Neurophysiol. 2004 Oct;92(4):2071-82
pubmed: 15190089
Neuron. 2009 Jan 29;61(2):213-9
pubmed: 19186164
Neurosci Biobehav Rev. 2007;31(5):775-824
pubmed: 17445891
Sci Signal. 2017 Jan 24;10(463):
pubmed: 28119463